APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Live Attenuated Rotavirus Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oral Live Attenuated Rotavirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025179 pages

Choose your research edition.

Industry ResearchOral Live Attenuated Rotavirus Vaccine Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Live Attenuated Rotavirus Vaccine Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Oral Live Attenuated Rotavirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Live Attenuated Rotavirus Vaccine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Live Attenuated Rotavirus Vaccine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Oral Live Attenuated Rotavirus Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Oral Live Attenuated Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Live Attenuated Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Live Attenuated Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oral Live Attenuated Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Live Attenuated Rotavirus Vaccine include Merck Sharp & Dohme, Lanzhou Biological Products Research Institute, GSK and Bharat Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oral Live Attenuated Rotavirus Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Live Attenuated Rotavirus Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Live Attenuated Rotavirus Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral Live Attenuated Rotavirus Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Live Attenuated Rotavirus Vaccine Segment by Company

Merck Sharp & Dohme

Lanzhou Biological Products Research Institute

GSK

Bharat Biotech

Oral Live Attenuated Rotavirus Vaccine Segment by Type

Monovalent Vaccines

Combination Vaccines

Oral Live Attenuated Rotavirus Vaccine Segment by Application

Hospitals and Clinics

Vaccination Sites

Oral Live Attenuated Rotavirus Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Live Attenuated Rotavirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Live Attenuated Rotavirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Live Attenuated Rotavirus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Live Attenuated Rotavirus Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Live Attenuated Rotavirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oral Live Attenuated Rotavirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oral Live Attenuated Rotavirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oral Live Attenuated Rotavirus Vaccine Industry Trends Table 2. Oral Live Attenuated Rotavirus Vaccine Industry Drivers Table 3. Oral Live Attenuated Rotavirus Vaccine Industry Opportunities and Challenges Table 4. Oral Live Attenuated Rotavirus Vaccine Industry Restraints Table 5. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oral Live Attenuated Rotavirus Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Manufacturers Table 9. Global Oral Live Attenuated Rotavirus Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Oral Live Attenuated Rotavirus Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oral Live Attenuated Rotavirus Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oral Live Attenuated Rotavirus Vaccine Manufacturers, Product Type & Application Table 13. Global Oral Live Attenuated Rotavirus Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral Live Attenuated Rotavirus Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Monovalent Vaccines Table 17. Major Manufacturers of Combination Vaccines Table 18. Global Oral Live Attenuated Rotavirus Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2027-2032) & (K Units) Table 21. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2026) & (K Units) Table 25. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2027-2032) & (K Units) Table 26. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospitals and Clinics Table 29. Major Manufacturers of Vaccination Sites Table 30. Global Oral Live Attenuated Rotavirus Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 32. Global Oral Live Attenuated Rotavirus Vaccine Sales by Application (2027-2032) & (K Units) Table 33. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2026) & (K Units) Table 37. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2027-2032) & (K Units) Table 38. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Oral Live Attenuated Rotavirus Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Oral Live Attenuated Rotavirus Vaccine Sales by Region (2021-2026) & (K Units) Table 42. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Oral Live Attenuated Rotavirus Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Oral Live Attenuated Rotavirus Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Oral Live Attenuated Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 47. North America Oral Live Attenuated Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 48. Europe Oral Live Attenuated Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 50. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Oral Live Attenuated Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Oral Live Attenuated Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 57. Global Oral Live Attenuated Rotavirus Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2027-2032) Table 62. Merck Sharp & Dohme Company Information Table 63. Merck Sharp & Dohme Business Overview Table 64. Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Product Portfolio Table 66. Merck Sharp & Dohme Recent Development Table 67. Lanzhou Biological Products Research Institute Company Information Table 68. Lanzhou Biological Products Research Institute Business Overview Table 69. Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Product Portfolio Table 71. Lanzhou Biological Products Research Institute Recent Development Table 72. GSK Company Information Table 73. GSK Business Overview Table 74. GSK Oral Live Attenuated Rotavirus Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. GSK Oral Live Attenuated Rotavirus Vaccine Product Portfolio Table 76. GSK Recent Development Table 77. Bharat Biotech Company Information Table 78. Bharat Biotech Business Overview Table 79. Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Product Portfolio Table 81. Bharat Biotech Recent Development Table 82. Key Raw Materials Table 83. Raw Materials Key Suppliers Table 84. Oral Live Attenuated Rotavirus Vaccine Distributors List Table 85. Oral Live Attenuated Rotavirus Vaccine Customers List Table 86. Research Programs/Design for This Report Table 87. Authors List of This Report Table 88. Secondary Sources Table 89. Primary Sources List of Figures Figure 1. Oral Live Attenuated Rotavirus Vaccine Product Image Figure 2. Global Oral Live Attenuated Rotavirus Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Live Attenuated Rotavirus Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Live Attenuated Rotavirus Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Oral Live Attenuated Rotavirus Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Oral Live Attenuated Rotavirus Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Monovalent Vaccines Image Figure 9. Combination Vaccines Image Figure 10. Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Hospitals and Clinics Image Figure 17. Vaccination Sites Image Figure 18. Global Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Oral Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Oral Live Attenuated Rotavirus Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Oral Live Attenuated Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Oral Live Attenuated Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Oral Live Attenuated Rotavirus Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Oral Live Attenuated Rotavirus Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Monovalent Vaccines
  • Combination Vaccines
Applications
  • Hospitals and Clinics
  • Vaccination Sites
Companies covered
  • Merck Sharp & Dohme
  • Lanzhou Biological Products Research Institute
  • GSK
  • Bharat Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oral Live Attenuated Rotavirus Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oral Live Attenuated Rotavirus Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oral Live Attenuated Rotavirus Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oral Live Attenuated Rotavirus Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oral Live Attenuated Rotavirus Vaccine Market Dynamics
  1. 2.1 Oral Live Attenuated Rotavirus Vaccine Industry Trends
  2. 2.2 Oral Live Attenuated Rotavirus Vaccine Industry Drivers
  3. 2.3 Oral Live Attenuated Rotavirus Vaccine Industry Opportunities and Challenges
  4. 2.4 Oral Live Attenuated Rotavirus Vaccine Industry Restraints
3 Oral Live Attenuated Rotavirus Vaccine Market by Manufacturers
  1. 3.1 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oral Live Attenuated Rotavirus Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oral Live Attenuated Rotavirus Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oral Live Attenuated Rotavirus Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Live Attenuated Rotavirus Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oral Live Attenuated Rotavirus Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Oral Live Attenuated Rotavirus Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Live Attenuated Rotavirus Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Live Attenuated Rotavirus Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Live Attenuated Rotavirus Vaccine Tier 1, Tier 2, and Tier 3
4 Oral Live Attenuated Rotavirus Vaccine Market by Type
  1. 4.1 Oral Live Attenuated Rotavirus Vaccine Type Introduction
  2. 4.1.1 Monovalent Vaccines
  3. 4.1.2 Combination Vaccines
  4. 4.2 Global Oral Live Attenuated Rotavirus Vaccine Sales by Type
  5. 4.2.1 Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Type
  9. 4.3.1 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2021-2032)
5 Oral Live Attenuated Rotavirus Vaccine Market by Application
  1. 5.1 Oral Live Attenuated Rotavirus Vaccine Application Introduction
  2. 5.1.1 Hospitals and Clinics
  3. 5.1.2 Vaccination Sites
  4. 5.2 Global Oral Live Attenuated Rotavirus Vaccine Sales by Application
  5. 5.2.1 Global Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Application
  9. 5.3.1 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2021-2032)
6 Global Oral Live Attenuated Rotavirus Vaccine Sales by Region
  1. 6.1 Global Oral Live Attenuated Rotavirus Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral Live Attenuated Rotavirus Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Oral Live Attenuated Rotavirus Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Oral Live Attenuated Rotavirus Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oral Live Attenuated Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oral Live Attenuated Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oral Live Attenuated Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Region
  1. 7.1 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Region
  2. 7.1.1 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Oral Live Attenuated Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Oral Live Attenuated Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oral Live Attenuated Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck Sharp & Dohme
  2. 8.1.1 Merck Sharp & Dohme Company Information
  3. 8.1.2 Merck Sharp & Dohme Business Overview
  4. 8.1.3 Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Product Portfolio
  6. 8.1.5 Merck Sharp & Dohme Recent Developments
  7. 8.2 Lanzhou Biological Products Research Institute
  8. 8.2.1 Lanzhou Biological Products Research Institute Company Information
  9. 8.2.2 Lanzhou Biological Products Research Institute Business Overview
  10. 8.2.3 Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Product Portfolio
  12. 8.2.5 Lanzhou Biological Products Research Institute Recent Developments
  13. 8.3 GSK
  14. 8.3.1 GSK Company Information
  15. 8.3.2 GSK Business Overview
  16. 8.3.3 GSK Oral Live Attenuated Rotavirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GSK Oral Live Attenuated Rotavirus Vaccine Product Portfolio
  18. 8.3.5 GSK Recent Developments
  19. 8.4 Bharat Biotech
  20. 8.4.1 Bharat Biotech Company Information
  21. 8.4.2 Bharat Biotech Business Overview
  22. 8.4.3 Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Product Portfolio
  24. 8.4.5 Bharat Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral Live Attenuated Rotavirus Vaccine Value Chain Analysis
  2. 9.1.1 Oral Live Attenuated Rotavirus Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral Live Attenuated Rotavirus Vaccine Production Mode & Process
  6. 9.2 Oral Live Attenuated Rotavirus Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral Live Attenuated Rotavirus Vaccine Distributors
  9. 9.2.3 Oral Live Attenuated Rotavirus Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst